Prostate Cancer Probability after Total PSA and Percent Free PSA Determination
The International Journal of Biological Markers, 1998 The percent free PSA value is a promising diagnostic tool for prostate cancer. However, its actual role has not yet been established because of the widely diverging sensitivity and specificity values.
R. Mione +14 more
doaj +6 more sources
The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy [PDF]
Biomedicines, 2020 The main advantage of urinary biomarkers is their noninvasive character and the ability to detect multifocal prostate cancer (CaP). We have previously implemented a quadruplex assay of urinary markers into clinical practice (PCA3, AMACR, TRPM8 and MSMB ...
Zlata Huskova +5 more
doaj +2 more sources
Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination [PDF]
International Brazilian Journal of Urology, 2004 OBJECTIVES: The risks of identifying prostate cancer (PCa) in patients with serum total PSA (tPSA) between 4 and 10 ng/dl are between 25 and 35%. There are no data in Brazil showing the incidence of disease when all variables for PSA assessment are ...
Ari Miotto Jr +5 more
doaj +4 more sources
Study of Serum Total PSA and Free PSA as an Oncological Marker in Breast Tumour [PDF]
Journal of Clinical and Diagnostic Research, 2017 Introduction: Breast Cancer (BC) cases are rising alarmingly all over the world and India is not an exception. This rising trend is due to an increased age at first child birth, decreased breast feeding, and the changing lifestyle mostly in urban ...
Elteza Tahjiba Jahir +2 more
doaj +2 more sources
Free PSA: A better molecular marker than total PSA for breast cancer
Asian Journal of Medical Sciences, 2014 Serum total PSA (prostate specific antigen) has been considered since some time for diagnosis or prognosis of breast cancer. PSA is present both as free and complexed form.
Rachita Nanda
doaj +3 more sources
Total PSA and free PSA in patients with severe liver dysfunction
Indian Journal of Urology, 2003 Objectives: To evaluate the effect of liver diseases in patients, on serum free prostate specific antigen (JPSA) levels, total prostate specific antigen (tPSA) levels and fPSA/tPSA ratios.
Rama Devi Mittal +3 more
doaj +2 more sources
Prognosis of patients with early salvage radiotherapy and low persisting or increasing PSA levels after radical prostatectomy for prostate cancer. A retrospective comparative analysis [PDF]
Clinical and Translational Radiation OncologyTitle: Prognosis of patients with early salvage radiotherapy and low persisting or increasing PSA levels after radical prostatectomy for prostate cancer. A retrospective comparative analysis.
Reinhard Thamm +8 more
doaj +2 more sources
Utility of prostate-specific antigen derivatives to minimize unnecessary magnetic resonance imaging in patients with prior negative prostate biopsy [PDF]
Scientific ReportsMagnetic resonance imaging (MRI) has become an important tool for recommending prostate biopsy (PB) in prostate cancer (PCa) detection. However, the routine use of MRI in patients with previous negative PB remains debatable.
Sangchul Lee +8 more
doaj +2 more sources
Intermethod Differences in Results for Total PSA, Free PSA, and Percentage of Free PSA [PDF]
American Journal of Clinical Pathology, 2008 Serum prostate-specific antigen (PSA) assays differ in calibration and response to different PSA forms. We examined intermethod differences in total PSA (tPSA) and free PSA (fPSA) measurements. We tested 157 samples with tPSA concentrations of 2 to 10 ng/mL (2-10 microg/L) using 6 PSA/fPSA method pairs and 1 tPSA method: ADVIA Centaur (complexed and ...
Patricia R, Slev +2 more
openaire +2 more sources
Label-Free Determination of PSA and Free PSA Using MA-SERS
Frontiers in Analytical Science, 2022 Prostate cancer is one of the compelling types of cancer diagnosed in men. Development of screening analytical methods, which provide fast and reliable results is, thus, demanding. Currently applied methods are usually based on the determination of serum prostate-specific antigen (PSA), where several limitations were identified.
Chaloupková, Zuzana +4 more
openaire +1 more source